{"doc_desc":{"title":"Cohorte sur les traitements de l\u2019abus et de la d\u00e9pendance au cannabis chez l\u2019adolescent","idno":"FRESH-PEF4363-fr","producers":[{"name":"Bruno FALISSARD","affiliation":"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)"}]},"study_desc":{"title_statement":{"idno":"FRESH-PEF4363-fr","IDno":{"metadata_no":[{"agency":"PEF","code":"4363"},{"agency":"FReSH","code":"FRESH-PEF4363"}]},"title":"Cohorte sur les traitements de l\u2019abus et de la d\u00e9pendance au cannabis chez l\u2019adolescent","alternate_title":"INCANT"},"study_authorization":{"agency":[{"name":"CNIL"}]},"authoring_entity":[{"type":"investigator","name":"C\u00e9line;JOUANNE","PILabo":"Tolbiac Emergency Resource Centre","affiliationName":"FONDATION L ELAN RETROUVE","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"IdRef","uri":"201430401","role":"pi id"},{"title":"SIREN","uri":"775676349","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"jouanne.celine@neuf.fr","isContact":"Oui"},{"type":"investigator","name":"Bruno;FALISSARD","PILabo":"National Institute of Health and Medical Research \/ INSERM U669","affiliationName":"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)","extlink":[{"title":"ORCID","uri":"0000-0002-2418-4954","role":"pi id"},{"title":"IdRef","uri":"034648739","role":"pi id"},{"title":"SIREN","uri":"180036048","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"bruno.falissard@universite-paris-saclay.fr","isContact":"Oui"},{"type":"investigator","name":"Olivier;PHAN","PILabo":"National Institute of Health and Medical Research \/ INSERM U669","affiliationName":"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)","extlink":[{"title":"","uri":"","role":"pi id"},{"title":"IdRef","uri":"136183921","role":"pi id"},{"title":"SIREN","uri":"180036048","role":"organisation id"},{"title":"","uri":"","role":"labo id"}],"email":"olivier.phan@fsef.net","isContact":"Oui"}],"oth_id":[{"name":""}],"production_statement":{"prod_place":"Portail Epid\u00e9miologie France (PEF)","producers":[{"name":"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)","extlink":[{"title":"ROR","uri":"https:\/\/ror.org\/02vjkv261","role":"sponsor id"},{"title":"SIREN","uri":"180036048","role":"sponsor id"}],"role":"sponsor"},{"name":"","extlink":[],"role":"sponsor"}],"funding_agencies":[{"name":""}]},"distribution_statement":{"contact":[{"name":"C\u00e9line;JOUANNE","email":"jouanne.celine@neuf.fr","type":"contact","affiliationName":"FONDATION L ELAN RETROUVE","contactPointLabo":"","extlink":[{"uri":"775676349","role":"organisation id","title":"SIREN"}]},{"name":"Bruno;FALISSARD","email":"bruno.falissard@universite-paris-saclay.fr","type":"contact","affiliationName":"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/02vjkv261","role":"organisation id","title":"ROR"},{"uri":"180036048","role":"organisation id","title":"SIREN"}]},{"name":"Olivier;PHAN","email":"olivier.phan@fsef.net","type":"contact","affiliationName":"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)","contactPointLabo":"","extlink":[{"uri":"https:\/\/ror.org\/02vjkv261","role":"organisation id","title":"ROR"},{"uri":"180036048","role":"organisation id","title":"SIREN"}]}]},"study_info":{"keywords":[{"keyword":"protocole"},{"keyword":"Cannabis"},{"keyword":"traitement"},{"keyword":"th\u00e9rapie familiale"},{"keyword":"abus"},{"keyword":"adolescent"},{"keyword":"\u00e9valuation"}],"topics":[{"topic":"P\u00e9diatrie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/bf8aaaac-ddee-41cd-bb8a-c5a63de3fcbd"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D010372"}]},{"topic":"Psychiatrie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/3de50dee-da1c-4791-a386-56bca24a5fed"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D011570"}]},{"topic":"Addictologie","vocab":"health theme","extLink":[{"title":"ESV","uri":"http:\/\/data.europa.eu\/8mn\/euroscivoc\/42d645e0-f58d-40ed-9917-5b227ff41a92"},{"title":"MeSH","uri":"http:\/\/id.nlm.nih.gov\/mesh\/D000073316"}]},{"topic":"Troubles dus \u00e0 des comportements addictifs","vocab":"cim-11","extLink":[{"uri":"http:\/\/id.who.int\/icd\/entity\/499894965","title":"CIM-11"}]},{"topic":"D\u00e9terminants comportementaux : Addictions","vocab":"health determinant"},{"topic":"D\u00e9terminants socio-d\u00e9mographiques et \u00e9conomiques","vocab":"health determinant"},{"topic":"D\u00e9terminants comportementaux","vocab":"health determinant"}],"purpose":"Evaluer l\u2019int\u00e9r\u00eat d\u2019une th\u00e9rapie sp\u00e9cifique, la Th\u00e9rapie familiale multidimensionnelle (Multidimensional family therapy \u2013 MDFT) dans la prise en charge des adolescents abuseurs ou d\u00e9pendants du cannabis. Valider une m\u00e9thode th\u00e9rapeutique, dans le contexte europ\u00e9en et plus particuli\u00e8rement fran\u00e7ais, efficace dans le champ des addictions \u00e0 l\u2019adolescence ; d\u00e9velopper des moyens d\u2019\u00e9valuation des psychoth\u00e9rapies.","abstract":"","coll_dates":[{"start":"2006-01-01","end":"2009-01-01"}],"nation":[{"name":"France","abbreviation":"fr","extLink":{"vocab":"ISO","vocabURI":"fr"}},{"name":"Pays-Bas","abbreviation":"nl","extLink":{"vocab":"ISO","vocabURI":"nl"}},{"name":"Allemagne","abbreviation":"de","extLink":{"vocab":"ISO","vocabURI":"de"}},{"name":"Suisse","abbreviation":"ch","extLink":{"vocab":"ISO","vocabURI":"ch"}},{"name":"Belgique","abbreviation":"be","extLink":{"vocab":"ISO","vocabURI":"be"}}],"geog_coverage":"","analysis_unit":"Individus","universe":"{\n    \"level_sex_clusion_I\": [\n        {\n            \"value\": \"Masculin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D008297\"\n            }\n        },\n        {\n            \"value\": \"F\u00e9minin\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D005260\"\n            }\n        }\n    ],\n    \"level_age_clusion_I\": [\n        {\n            \"value\": \"Adolescence (13 \u00e0 18 ans)\",\n            \"concept\": {\n                \"vocab\": \"MeSH\",\n                \"vocabURI\": \"http:\\\/\\\/id.nlm.nih.gov\\\/mesh\\\/D000293\"\n            }\n        }\n    ],\n    \"level_type_clusion_I\": \"Patients\",\n    \"level_type_clusion_other\": \"\",\n    \"clusion_I\": \"Pr\u00e9senter un diagnostic d\u2019abus ou de d\u00e9pendance au cannabis, et avoir au moins un parent (ou repr\u00e9sentant l\u00e9gal) acceptant de participer \u00e0 la th\u00e9rapie et \u00e0 l\u2019\u00e9tude. \u00c0 noter que l\u2019abus d\u2019autres substances psychoactives, les troubles du comportement et\\\/ou les troubles psychiatriques, souvent associ\u00e9s \u00e0 la consommation de cannabis, ne constituent pas un crit\u00e8re d\u2019exclusion.\",\n    \"clusion_E\": \"\"\n}","data_kind":"['Donn\u00e9es cliniques','Donn\u00e9es rapport\u00e9es par le participant de l&#x27;\u00e9tude','Donn\u00e9es paracliniques','Donn\u00e9es paracliniques (hors biologiques) : Autre']","quality_statement":{"standards":[{"name":"","committee":"","governance":""}],"other_quality_statement":""}},"study_development":{"development_activity":[{"activity_type":"primary evaluation","activity_description":"Ev\u00e9nements de sant\u00e9\/morbidit\u00e9"}]},"method":{"data_collection":{"time_method":"","frequency":"","sampling_procedure":"['{\"concept\":{\"vocabURI\":\"Other\",\"vocab\":\"CESSDA\"},\"value\":\"Autre\"}']","sample_frame":{"frame_unit":{"unit_type":"['Via des structures (services ou \u00e9tablissements de sant\u00e9, \u00e9coles, entreprises\u2026)']"}},"coll_mode":["{\"concept\":{\"vocabURI\":\"SelfAdministeredQuestionnaire\",\"vocab\":\"CESSDA\"},\"value\":\"Questionnaire auto-administr\u00e9\"}","{\"concept\":{\"vocabURI\":\"Interview\",\"vocab\":\"CESSDA\"},\"value\":\"Entretien avec le participant (dont clinique)\"}"],"research_instrument":"Acc\u00e8s restreint sur projet sp\u00e9cifique","sources":[],"target_sample_size":"< 500 individus","response_rate":"150"},"method_notes":"Etude observationnelle","study_class":"Inconnu","notes":[{"subject":"research type","values":["Etude observationnelle"]},{"subject":"observational study method","values":["Cohorte"]}]},"data_access":{"dataset_availability":{"access_place":"","complete":"","status":"{\"value\":\"Acc\u00e8s r\u00e9serv\u00e9\",\"extLink\":[{\"title\":\"COAR\",\"uri\":\"http:\/\/purl.org\/coar\/access_right\/c_16ec\"}]}"},"dataset_use":{"restrictions":"","conditions":"Contacter le responsable scientifique","conf_dec":[{"txt":""}],"spec_perm":[{"txt":"","required":""}],"contact":[{"name":""}],"deposit_req":"","cit_req":""},"notes":""}},"additional":{"IsImport":true,"versionLang":"fr","originLang":"fr","autoTranslation":false,"status":"imported","creationDate":"15-10-2012","lastUpdatedAuto":null,"lastUpdatedManual":"01-12-2019","isContributorPI":"Non","contributorName":"Bruno FALISSARD","contributorAffiliation":"INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)","addTeamMember":"","obtainedAuthorization":{"otherAuthorizingAgency":[""]},"relatedDocument":[{"type":"","title":"","link":"http:\/\/www.mdft.org\/mdft\/media\/files\/Jouanne-et-al-%28comparaison-de-l-efficacite-de-la-MultiDimensional-Family-Therapy-%28MDFT%29-versus-la-Treatment-as-usual-Explicite.pdf"}],"regulatoryRequirements":{"conformityDeclaration":""},"fundingAgent":{"fundingAgentType":[],"otherFundingAgentType":[]},"sponsor":{"sponsorType":["Public (France)","Public (France)"],"otherSponsorType":["",""]},"governance":{"committee":""},"collaborations":{"networkConsortium":""},"theme":{"complementaryInformation":"","RareDiseases":""},"activeFollowUp":{"isActiveFollowUp":"Oui","followUpModeOther":""},"interventionalStudy":{"researchPurpose":[],"trialPhase":[],"interventionalStudyModel":"","isClinicalTrial":"","otherResearchPurpose":""},"isInclusionGroups":"","allocation":{"allocationMode":"","allocationUnit":""},"masking":{"maskingType":"","blindedMaskingDetails":[]},"arms":[],"intervention":[],"inclusionGroups":[],"collectionProcess":{"collectionModeDetails":"Auto-questionnaire (Intake Interview, PEI, YSR, CBCL, ADRS) et entretien m\u00e9dical (Timeline Follow-Back method, ADI-Light","collectionModeOther":""},"dataCollection":{"inclusionStrategyOther":"","samplingModeOther":"","recruitmentSourceOther":"","otherDocumentation":""},"dataCollectionIntegration":{"isDataIntegration":"Non"},"geographicalCoverage":{"geoDetail":"Europe: France, Pays-Bas, Allemagne, Suisse, Belgique. En France, En France, les adolescents et leurs parents sont recrut\u00e9s au sein de deux centres sp\u00e9cialis\u00e9s dans les addictions aux substances psychoactives et offrant une Consultation Jeunes Usagers selon le protocole de la MILDT : le Centre Emergence Espace Tolbiac, rattach\u00e9 \u00e0 l\u2019Institut Mutualiste Montsouris (Paris, XIIIe arrondissement), et le Centre de soins sp\u00e9cifiques pour toxicomanes CSST centre d'aide aux toxicomanes CEDAT de Mantes-la-Jolie qui d\u00e9pend de l\u2019h\u00f4pital Mignot de Versailles."},"dataTypes":{"clinicalDataDetails":"","biologicalDataDetails":"","isDataInBiobank":"Oui","biobankContent":[],"biobankContentOther":"","dataTypeOther":""},"variableDictionnary":{"variableDictionnaryAvailable":"","variableDictionnaryLink":""},"dataQuality":{"otherDocumentation":""},"mockSample":{"mockSampleAvailable":"","mockSampleLocation":""},"thirdPartySource":{"otherSourceType":[]},"isHealthTheme":"Oui","fileDscr":{"fileTxt":{"fileCitation":{"titlStmt":{"IDno":[]}}}}},"schematype":"survey"}